Recent Developments in Convenience of Administration of the Anti-CD38 Antibody Isatuximab: Subcutaneous Delivery and Fast Intravenous Infusion in Patients With Multiple Myeloma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Recent Developments in Convenience of Administration of the Anti-CD38 Antibody Isatuximab: Subcutaneous Delivery and Fast Intravenous Infusion in Patients With Multiple Myeloma

Published:2024-06 Issue:6 Volume:24 Page:358-363
ISSN:2152-2650
Container-title:Clinical Lymphoma Myeloma and Leukemia
language:en
Short-container-title:Clinical Lymphoma Myeloma and Leukemia

Author:

Quach Hang^ORCID,Parmar Gurdeep,Mateos Maria-Victoria,Ailawadhi Sikander,Leleu Xavier

Funder

Sanofi Australia

Sanofi-Aventis US LLC

Publisher

Elsevier BV

Reference51 articles.

1. Relapsed/refractory multiple myeloma in 2020/2021 and beyond;Podar;Cancers (Basel),2021

2. Multiple myeloma: 2022 update on diagnosis, risk stratification, and management;Rajkumar;Am J Hematol,2022

3. Multiple myeloma: EHA-ESMO clinical practice guidelines for diagnosis, treatment and follow-up;Dimopoulos;Hemasphere,2021

4. Maples KT, Johnson C, Lonial S. Antibody treatment in multiple myeloma. Clin Adv Hematol Oncol. 2021;19:166-174.

5. Anti-CD38 antibody therapy for patients with relapsed/refractory multiple myeloma: differential mechanisms of action and recent clinical trial outcomes;Leleu;Ann Hematol,2022

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Al/ZnO nanoparticle as an effective nanocarrier in delivery of lenalidomide anti-multiple myeloma cancer drug;Materials Technology;2024-04-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP